Skip to content
drillr.ai
Sign up

688488.SH

艾迪药业

SSE · Healthcare · Biotechnology · CN

CNY 15.93
−3.40%
Ask drillr

  • Aug 28, 2026, 09:20 UTC

    Aide Pharmaceutical announced its first-half 2026 results with revenue of 366 million yuan, up 0.93% year-on-year, and net profit attributable to shareholders of 22.93 million yuan, up 149.53% year-on-year.

    Source:

  • Aug 18, 2026, 08:04 UTC

    Fu Hexiang, a person acting in concert with the actual controller of Aidea Pharmaceutical, pledged 4.5 million shares of the company to Shenzhen Shendan Credit Enhancement Financing Guarantee Co., Ltd. on August 17, 2026, for personal funding needs.

    Source: